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Gordon research conference programs 
Natural products chemistry 
July 2-7,1995 
New England College 
Henniker, NH, USA 
Synthetic chemistry 
Robert K Boeckman, Jr, University of Rochester, USA: 
New developments and applications of bicyclic 
lactam based chiral controller molecules to 
asymmetric synthesis 
Stephen L Buchwald, Massachusetts Institute of Tech- 
nology, USA: A catalytic method for the formation 
of carbon-nitrogen bonds 
Dennis P Curl-an, University of Pittsburgh, USA: Recent 
applications of radical reactions in organic synthesis 
Scott E Denmark, University of Illinois, USA: Tandem 
cycloadditions of nitroalkenes in natural product 
synthesis 
Eiichi Nakamura, Tokyo Institute of Technology, Japan: 
Organic chemistry of Buckminsterfullerenes 
Scott D Rychnovsky, University of Minnesota, USA: 
Structures, syntheses and biological activities of 
polyene macrolide antibiotics 
K Barry Sharpless, Scripps Research Institute, USA: 
Noncovalent binding phenomena in asymmetric 
catalysis 
Keisuke Suzuki, Keio University, Japan: Synthetic 
strategies for natural products with arene-sugar 
and arene-isoprenoid hybrid structures 
Natural products isolation and 
structure elucidation 
Eric Block, State University of New York at Albany, 
USA: Isolation, structure elucidation, synthesis and 
study of organoselenium and organosulfur natural 
products from common plants and vegetables: 
recent results 
Daniel Schroeder, Bristol-Myers Squibb Research Institute, 
USA: Studies on maduropeptin chromophore 
Sheo B Singh, Merck Research Laboratories, USA: 
Isolation, structure and synthesis of inhibitors of 
endonuclease and Ras farnesyl-protein transferase 
Wolfgang Steglich, University of Munich, Germany: 
Hunting the mushrooms for chemicals 
Bioorganic chemistry of natural products 
Jon C Clardy, Cornell University, USA: Natural products 
and their macromolecular receptors 
Daniel E Kahne, Princeton University, USA: Chromo- 
mycin as a blueprint for designed metal complexes 
Alanna Schepartz,Yale University, USA: The chemistry 
of transcriptional activation 
Natural products and drug discovery 
Bruce A Lefker, Pfizer Central Research, USA: Structure- 
based design of non-peptide renin inhibitors 
Michael Lewis, Eisai Research Institute, USA: Inhibitors 
of isoprenyl transferases 
Daniel Sternbach, Glaxo Research Institute, USA: 
Progress toward small molecule inhibitors of src 
SH3SH2/phosphoprotein interactions 
Molecular diversity and natural products 
Manoj Desai, Chiron Corporation, USA: Recent 
advances in the generation of chemical diversity 
libraries 
Jonathan A Ellman, University of California, Berkeley, 
USA: Simultaneous synthesis and evaluation of 
organic compound libraries 
Michael Ohlmeyer, Pharmacopeia, Inc., USA: Encoded 
organic syntheses 
Applications may be found in the February 3 issue 
of Science or requested from the conference chairmen: 
Rick L Danheiser, PhD, Chair 
Department of Chemistry 
Massachusetts Institute ofTechnology 
Cambridge, MA 02139, USA 
Tel: 617 253 1842 Fax: 617 258 7500 
William R Baker, PhD,Vice chair 
Pathogenesis Corporation 
201 Elliot Avenue, West 
Seattle, WA 98119, USA 
Tel: 206 270 3310 Fax: 206 282 5065 
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Purines, pyrimidines and 
related substances 
July 2-7, 1995 
Salve Regina University 
Newport, RI, USA 
Enzyme mechanisms: deaminases 
Charles W Carter Jr, University of North Carolina at 
Chapel Hill, USA: Cytidine deaminase: crystal 
structure of an enzyme:transition-state complex 
Richard Wolfenden, University of North Carolina at 
Chapel Hill, USA: Extreme examples of structural 
discrimination by deaminases: results of substrate 
and site-directed modifications 
Larry Chan, Baylor College of Medicine, USA: Apo- 
lipoprotein B mRNA editing protein: structure and 
biological significance 
Enzyme mechanisms: DNA methylases 
Xiaodong Cheng, Cold Spring Harbor Laboratory, USA: 
DNA modification by methyltransferases 
Judy K Christman, University of Nebraska, USA: Use 
of cytidine analogs in defined oligodeoxyribo- 
nucleotides to explain the mechanism of action of 
mammalian DNA methyltransferase ’ 
Enzyme mechanisms: dehydrogenases 
Krzysztof W Pankiewicz, Memorial Sloan-Kettering 
Cancer Center, USA: Synthesis of NAD analogs 
designed as potential anticancer agents 
Barry M Goldstein, University of Rochester, USA: 
Crystallographic studies of dehydrogenase-inhibitor 
complexes: structural determinants of specificity 
, 
Structure and function of nucleic acids 
and oligonucleotides 
Jyoti Chattopadhyaya, University of Upsala, Sweden: 
How do the gauche and anomeric effects drive the 
pseudorotational equilibrium of the pentofuranose 
moiety of nucleosides? 
Cornelis Altona, Leiden University, Netherlands: 
Three-way and four-way junctions in DNA 
Shih-Fong Chen, Institute for Drug Development, 
USA: Interference of telomere/telomerase activity 
by nucleoside/nucleotide analogs 
Carbocyclic nucleosides 
Stewart W Schneller, Auburn University, USA: 
5’-Norcarbocyclic nucleosides and nucleotides 
Ronald J Parry, Rice University, USA: Recent in- 
vestigations of the biosynthesis of carbocyclic 
nucleosides 
Karl H Altmann, Ciba-Geigy, Basel, Switzerland: 
6’-Substituted carbocyclic nucleosides: a novel 
class of oligonucleotide building blocks 
Biochemistry and pharmacology 
Thomas Spector, Wellcome Research Laboratories, 
Research Triangle Park, USA: 5-Ethynyluracil 
(776(X5)/5-fluorouracil: preclinical and clinical 
studies 
Joseph Bertino, Memorial Sloan-Kettering Cancer 
Center, USA: Protracted use of 5-FU and the 
re-establishment of sensitivity: new scheduling 
protocols 
Walter Wolf, University of Southern California, 
Los Angeles, USA: Tumoral pharmacokinetics 
of antitumor drugs can be estimated from 
non-invasive measurements, such as 19F MRS 
and ‘*F PET 
Synthetic methodology 
Michael E Jung, University of California, Los Angeles, 
USA: New synthetic methods for the preparation 
of nucleoside analogs 
Tarek S Mansour, BioChem Therapeutic, Inc., Canada: 
Challenges and solutions to the diastereoselective 
synthesis of 2’,3’-dideoxy and heterosubstituted 
nucleoside analogs 
Oligonucleotides: synthesis, structure 
and function 
Leigh Anderson, Large Scale Biology Corporation, USA: 
Large scale solid-phase synthesis of oligonucleotides 
in centrifugal systems 
Hideo Inoue, Hokkaido University, Japan: A specific 
reaction of a damage base S-oxoguanine residue 
in DNA fragments starts successive modifications 
on the neighboring nucleotide residues 
Yogesh Sanghvi, ISIS Pharmaceutical, USA: Beyond 
phosphorothioates: second- generation antisense 
oligonucleotides 
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Pro-drugs 
Elie Abushanab, University of Rhode Island, USA: Neutral 
phosphotriesters as novel drug delivery systems 
Gilles Gosselin, University of Montpellier, France: 
Neutral nucleotides bearing enzyme-labile tran- 
sient phosphate protecting groups: antiviral and 
antitumor pro-drugs endowed with enhanced 
potency and bioavailability 
Applications may be found in the February 3 issue 
of Science or requested from the conference chairmen: 
Victor E Marquez, PhD, Chair 
Laboratory of Medicinal Chemistry 
National Cancer Institute 
National Institutes of Health 
Bethesda, MD 20892, USA 
Tel: 301 496 8065 Fax: 301 402 2275 
Thomas Spector, PhD,Vice chair 
Department of ExperimentalTherapy 
Wellcome Research Laboratories 
3030 Cornwallis Road 
Research Triangle Park, NC 27709-2700, USA 
Tel: 919 315 4344 Fax: 919 315 8597 
